Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?

首页> 外文期刊>Singapore medical journal >Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?

【24h】

Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?

机译：唑来膦酸治疗的非转移性前列腺癌患者的非典型股骨干骨折：治疗效果还是巧合？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Singapore medical journal》 |2012年第3期|共页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-na?ve metastatic prostate cancer patients – A propensity scoring approach [J] . Kazuhiro Nagao, Hideyasu Matsuyama, Masahiro Nozawa, Asian Journal of Urology . 2016,第1期

机译：唑来膦酸联合雄激素剥夺疗法可延长未接受过激素治疗的转移性前列腺癌患者去势抵抗性前列腺癌的时间–一种倾向性评分方法
2. Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer [J] . DenhamJ.W., NowitzM., JosephD., BJU international . 2014,第3期

机译：跨塔斯曼放射肿瘤学组（TROG）雄激素抑制和唑来膦酸对骨矿物质密度和骨折的影响03.04局部晚期前列腺癌的随机性雄激素剥夺和放射治疗（RADAR）随机对照试验
3. Atypical femoral fracture in breast cancer patients with bone metastasis receiving denosumab therapy: multi-center retrospective analysis [J] . Ozaki Y., Takahashi M., Tanabe Y., The Breast : . 2019,第期

机译：乳腺癌患者的非典型股骨骨折接受Denosumab治疗：多中心回顾性分析
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy. [D] . Yong, Candice Yuk Chen. 2015

机译：用雄激素剥夺疗法治疗的非转移性前列腺癌医疗保险受益人骨折的成本和管理。
6. Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naïve metastatic prostate cancer patients – A propensity scoring approach [O] . Kazuhiro Nagao, Hideyasu Matsuyama, Masahiro Nozawa, 2016

机译：唑来膦酸联合雄激素剥夺疗法可延长未接受过激素治疗的转移性前列腺癌患者去势抵抗性前列腺癌的时间–一种倾向性评分方法
7. Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naïve metastatic prostate cancer patients – A propensity scoring approach [O] . Kazuhiro Nagao, Hideyasu Matsuyama, Masahiro Nozawa, 2016

机译：唑来膦酸联合雄激素剥夺疗法可延长激素初治转移性前列腺癌患者去势抵抗性前列腺癌的时间 - 倾向评分方法

Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?

著录项

相似文献

相关主题

期刊订阅